Bellevue Group AG provides asset management services in Switzerland, the United Kingdom, Germany, and internationally. The company offers healthcare investment solutions, including biotech, medtech, thematic, and healthcare global and regional. It also provides small and mid-sized entrepreneur investment solutions, such as listed small and mid caps, and private equity strategies; and multi asset, bonds, and alternatives. In addition, the company offers investment funds, as well as investment solutions for institutional, intermediary and private clients. The company was founded in 1993 and is headquartered in Zurich, Switzerland.
Metrics to compare | BBN | Sector Sector - Average of metrics from a broad group of related Financial sector companies | Relationship RelationshipBBNPeersSector | |
---|---|---|---|---|
P/E Ratio | 55.5x | 15.2x | 9.5x | |
PEG Ratio | −0.64 | 0.32 | 0.03 | |
Price/Book | 0.9x | 2.4x | 1.0x | |
Price / LTM Sales | 1.8x | 3.5x | 2.8x | |
Upside (Analyst Target) | - | −0.4% | 13.1% | |
Fair Value Upside | Unlock | 3.7% | 1.7% | Unlock |